| Date |
Topic |
Speaker |
| April 12 |
Drug Development: Where We Are and How We Got Here
Dr. Geary will discuss the history of drug development. How has the search for chemicals that usefully affect human biology developed, what factors were crucial in advancing the science behind drug discovery, and where do we stand today?
|
Timothy Geary, PhD |
| April 19 |
Personal Health Management: All for One, Not One for All
In the next two decades, patient care will move from uniform remedies to preventive and personalized medicine that treats diseases before you get sick. Dr. Papadopoulos will discuss recent advances that will transform drug development, design, and delivery.
|
Vassili Papadopoulos, PhD |
| April 26 |
The Genetics of Analgesia: Will We Have Customized Pain-Killers?
People differ in their responses to commonly prescribed pain medications because of environmental and genetic factors. Dr. Mogil will look at the possibilities and challenges of achieving individualized therapies for chronic pain.
|
Jeffrey Mogil, PhD |
| May 3 |
Cigarette Smoking: The Uncertain Role of Nicotine
Twenty years ago, the U.S. Surgeon General resoundingly concluded that nicotine is the drug in tobacco that causes addiction. Dr. Clarke will present a more nuanced view, highlighting different effects of cigarette smoking and cigarette smoke that may encourage the tobacco habit.
|
Paul Clarke, PhD |
| May 10 |
The Future of Medicine: Thinking Small
The use of nanobiotechnology in medicine is termed “nanomedicine.” Dr. Maysinger will discuss current advances in nanomedicine research, including targeted cancer therapies, localized drug delivery, and improved cell-material interactions for imaging of brain cells.
|
Dusica Maysinger, PhD |
| May 17 |
Are Chemicals in Our Environment Affecting Reproductive Health?
Over the past 50 years, our quality of life has improved thanks, in part, to a wide range of new chemicals. Some of these are now suspected of impairing fertility. Dr. Robaire will discuss the existing evidence and whether there are steps we should take to protect the next generation.
|
Bernard Robaire, PhD |
| May 24 |
The Pharmaceutical Industry and Society: Roles, Expectations, and Responsibility
Three panelists with varying perspectives will consider the role of the pharmaceutical industry in modern society. Is it just big business? Should we expect more from drug companies, given their important role in the treatment of human health and disease?
|
Panel Discussion:
Peter McLeod, MD
Tim Geary, PhD
Jeffrey Coull, PhD
Moderator:
Daniel Bernard, Ph.D.
|
